Like many epigenetic studies, the results of this investigation do not identify direction of causality; we are unable to ascertain if BD disease pathology results in SLC1A2 promoter hypermethylation or does SLC1A2 hypermethylation increase the risk of developing BD. Here, SLC1A2 is linked to Behcet disease.